Publicado em 20 out 2022
Prioritisation of COVID-19 boosters in the omicron era
The Lancet: Omicron and other variants of concern pose substantial challenges to optimising COVID-19 vaccination strategies. Thankfully, a growing body of literature shows that a COVID-19 vaccine booster dose protects against symptomatic omicron infection, and against hospitalisation with omicron infection, although protection is lower with more recently emerging omicron sublineages (ie, BA.4 and BA.5) compared with earlier variants.
Leia o artigo na íntegra em https://www.thelancet.com
